SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AFFYMETRIX (AFFX)
AFFX 14.010.0%Apr 1 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: lnkennedy who wrote (610)1/24/1998 4:05:00 PM
From: qz  Read Replies (1) of 1728
 
can someone explain affx's advantage over incyte, nanogen, and hyseq?

for gene differential expression analysis, i see the ink-jet printing
of ests as the most efficient/accurate approach. for profiling snps,
i believe nanogen's method is the most accurate. while affx can, in
principle, put more oligos on a chip, i fail to see the need to put, e.g. the entire genome on a single chip. in a way, affx doesn't really have
its own corner. let's not to forget that sequence by hybridization
WAS invented by hyseq, no matter what affx says.

i just hope that affx will not join those companies with a technology
that sounds great in theory, but can't translate into money in practice.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext